| 0 |
THROMBOCYTOPENIA |
13 |
| 1 |
DIARRHOEA |
12 |
| 2 |
FATIGUE |
12 |
| 3 |
COMPLETED SUICIDE |
10 |
| 4 |
PERICARDIAL EFFUSION |
10 |
| 5 |
CARDIAC FAILURE CONGESTIVE |
9 |
| 6 |
DRUG INEFFECTIVE |
9 |
| 7 |
DRUG INTERACTION |
9 |
| 8 |
HYPOVOLAEMIA |
9 |
| 9 |
ISCHAEMIC HEPATITIS |
9 |
| 10 |
MITRAL VALVE INCOMPETENCE |
9 |
| 11 |
OEDEMA PERIPHERAL |
9 |
| 12 |
PNEUMONIA |
9 |
| 13 |
RENAL INJURY |
9 |
| 14 |
RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED |
9 |
| 15 |
TRICUSPID VALVE INCOMPETENCE |
9 |
| 16 |
UPPER RESPIRATORY TRACT INFECTION |
9 |
| 17 |
DIFFERENTIATION SYNDROME |
8 |
| 18 |
FLUID OVERLOAD |
8 |
| 19 |
HEADACHE |
7 |
| 20 |
TOXICITY TO VARIOUS AGENTS |
7 |
| 21 |
OEDEMA |
6 |
| 22 |
OFF LABEL USE |
6 |
| 23 |
BRAIN OEDEMA |
5 |
| 24 |
CARDIAC ARREST |
5 |
| 25 |
CONJUNCTIVAL HAEMORRHAGE |
5 |
| 26 |
DEATH |
5 |
| 27 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
5 |
| 28 |
NAUSEA |
5 |
| 29 |
NEUTROPENIA |
5 |
| 30 |
VOMITING |
5 |
| 31 |
WHITE BLOOD CELL COUNT INCREASED |
5 |
| 32 |
ANAEMIA |
4 |
| 33 |
ARTERIOSCLEROSIS |
4 |
| 34 |
CARDIAC FAILURE |
4 |
| 35 |
CARDIOPULMONARY FAILURE |
4 |
| 36 |
CEREBRAL CONGESTION |
4 |
| 37 |
ELECTROCARDIOGRAM QT PROLONGED |
4 |
| 38 |
HAEMOTHORAX |
4 |
| 39 |
HYPERAEMIA |
4 |
| 40 |
HYPERHIDROSIS |
4 |
| 41 |
ILL-DEFINED DISORDER |
4 |
| 42 |
METAL POISONING |
4 |
| 43 |
MUSCLE SPASMS |
4 |
| 44 |
MYOCARDIAL INFARCTION |
4 |
| 45 |
NEURALGIA |
4 |
| 46 |
PARAESTHESIA ORAL |
4 |
| 47 |
PULMONARY CONGESTION |
4 |
| 48 |
PULMONARY OEDEMA |
4 |
| 49 |
ACUTE MYELOID LEUKAEMIA |
3 |
| 50 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
3 |
| 51 |
COVID-19 |
3 |
| 52 |
DELIRIUM |
3 |
| 53 |
HAEMATEMESIS |
3 |
| 54 |
HAEMATURIA |
3 |
| 55 |
LEUKAEMIA |
3 |
| 56 |
MYOCARDIAL ISCHAEMIA |
3 |
| 57 |
NEUROTOXICITY |
3 |
| 58 |
PERICARDITIS |
3 |
| 59 |
SOMNOLENCE |
3 |
| 60 |
TREMOR |
3 |
| 61 |
ACUTE HEPATIC FAILURE |
2 |
| 62 |
ADVERSE DRUG REACTION |
2 |
| 63 |
BLOOD ARSENIC INCREASED |
2 |
| 64 |
BLOOD CREATININE INCREASED |
2 |
| 65 |
BLOOD PRESSURE INCREASED |
2 |
| 66 |
CONSTIPATION |
2 |
| 67 |
DISEASE PROGRESSION |
2 |
| 68 |
DISTURBANCE IN ATTENTION |
2 |
| 69 |
DIZZINESS |
2 |
| 70 |
DRUG ABUSE |
2 |
| 71 |
ENCEPHALOPATHY |
2 |
| 72 |
FEELING ABNORMAL |
2 |
| 73 |
HAEMATOCRIT DECREASED |
2 |
| 74 |
HAEMATOPOIETIC NEOPLASM |
2 |
| 75 |
HERPES ZOSTER MENINGOENCEPHALITIS |
2 |
| 76 |
HYPERLEUKOCYTOSIS |
2 |
| 77 |
HYPOAESTHESIA |
2 |
| 78 |
HYPOTENSION |
2 |
| 79 |
INCORRECT DOSE ADMINISTERED |
2 |
| 80 |
INJECTION SITE MASS |
2 |
| 81 |
INJURY |
2 |
| 82 |
INTRACRANIAL PRESSURE INCREASED |
2 |
| 83 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
| 84 |
MYOCLONUS |
2 |
| 85 |
PANCYTOPENIA |
2 |
| 86 |
PARAESTHESIA |
2 |
| 87 |
PLATELET COUNT DECREASED |
2 |
| 88 |
POISONING |
2 |
| 89 |
PYREXIA |
2 |
| 90 |
RENAL FAILURE |
2 |
| 91 |
RESPIRATORY FAILURE |
2 |
| 92 |
SEIZURE |
2 |
| 93 |
SINUS TACHYCARDIA |
2 |
| 94 |
TACHYCARDIA |
2 |
| 95 |
TRANSAMINASES INCREASED |
2 |
| 96 |
ABDOMINAL PAIN |
1 |
| 97 |
ABDOMINAL PAIN UPPER |
1 |
| 98 |
ACNE |
1 |
| 99 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
| 100 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
| 101 |
ACUTE KIDNEY INJURY |
1 |
| 102 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
1 |
| 103 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
| 104 |
AMNESIA |
1 |
| 105 |
ARRHYTHMIA |
1 |
| 106 |
ASCITES |
1 |
| 107 |
ASPERGILLUS INFECTION |
1 |
| 108 |
ATAXIA |
1 |
| 109 |
AXONAL NEUROPATHY |
1 |
| 110 |
BLINDNESS |
1 |
| 111 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
| 112 |
BONE MARROW DISORDER |
1 |
| 113 |
BONE MARROW NECROSIS |
1 |
| 114 |
C-REACTIVE PROTEIN INCREASED |
1 |
| 115 |
CANDIDA INFECTION |
1 |
| 116 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
| 117 |
CHEST DISCOMFORT |
1 |
| 118 |
CHEST PAIN |
1 |
| 119 |
CHOLESTASIS |
1 |
| 120 |
CHROMOSOMAL DELETION |
1 |
| 121 |
CIRCULATORY COLLAPSE |
1 |
| 122 |
COGNITIVE DISORDER |
1 |
| 123 |
CONDITION AGGRAVATED |
1 |
| 124 |
COORDINATION ABNORMAL |
1 |
| 125 |
CYTOGENETIC ABNORMALITY |
1 |
| 126 |
DIABETES MELLITUS |
1 |
| 127 |
DIPLEGIA |
1 |
| 128 |
DISEASE COMPLICATION |
1 |
| 129 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 130 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
| 131 |
DRUG TOXICITY |
1 |
| 132 |
DUODENAL ULCER HAEMORRHAGE |
1 |
| 133 |
ENTEROBACTER BACTERAEMIA |
1 |
| 134 |
ERECTILE DYSFUNCTION |
1 |
| 135 |
EXPOSURE TO TOXIC AGENT |
1 |
| 136 |
FACE OEDEMA |
1 |
| 137 |
FAECAL ELASTASE CONCENTRATION DECREASED |
1 |
| 138 |
FEAR |
1 |
| 139 |
FEBRILE NEUTROPENIA |
1 |
| 140 |
FEELING HOT |
1 |
| 141 |
FLUSHING |
1 |
| 142 |
GAIT DISTURBANCE |
1 |
| 143 |
GAIT INABILITY |
1 |
| 144 |
GASTROINTESTINAL ANGIODYSPLASIA |
1 |
| 145 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
| 146 |
GOUT |
1 |
| 147 |
GRAFT VERSUS HOST DISEASE |
1 |
| 148 |
GRAFT VERSUS HOST DISEASE IN EYE |
1 |
| 149 |
GRAFT VERSUS HOST DISEASE IN LUNG |
1 |
| 150 |
GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
| 151 |
HAEMORRHAGE INTRACRANIAL |
1 |
| 152 |
HEPATITIS CHOLESTATIC |
1 |
| 153 |
HEPATOCELLULAR INJURY |
1 |
| 154 |
HERPES SIMPLEX |
1 |
| 155 |
HERPES ZOSTER |
1 |
| 156 |
HIDRADENITIS |
1 |
| 157 |
HYPERCALCAEMIA |
1 |
| 158 |
HYPERTENSION |
1 |
| 159 |
HYPERTRANSAMINASAEMIA |
1 |
| 160 |
HYPERVOLAEMIA |
1 |
| 161 |
HYPOXIA |
1 |
| 162 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
| 163 |
INFECTION |
1 |
| 164 |
INFREQUENT BOWEL MOVEMENTS |
1 |
| 165 |
INFUSION RELATED REACTION |
1 |
| 166 |
INJECTION SITE HAEMORRHAGE |
1 |
| 167 |
INJECTION SITE INDURATION |
1 |
| 168 |
INJECTION SITE PAIN |
1 |
| 169 |
INSOMNIA |
1 |
| 170 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 171 |
INTENTIONAL SELF-INJURY |
1 |
| 172 |
INTESTINAL PSEUDO-OBSTRUCTION |
1 |
| 173 |
JOINT SWELLING |
1 |
| 174 |
LEUKAEMIA RECURRENT |
1 |
| 175 |
LEUKOPENIA |
1 |
| 176 |
LIVER FUNCTION TEST INCREASED |
1 |
| 177 |
LOSS OF LIBIDO |
1 |
| 178 |
LUNG INFECTION |
1 |
| 179 |
LYMPHOPENIA |
1 |
| 180 |
MALABSORPTION |
1 |
| 181 |
MALAISE |
1 |
| 182 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
| 183 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 184 |
MEDICATION ERROR |
1 |
| 185 |
MENINGOENCEPHALITIS HERPETIC |
1 |
| 186 |
MENTAL DISORDER |
1 |
| 187 |
METABOLIC ACIDOSIS |
1 |
| 188 |
MULTI-ORGAN FAILURE |
1 |
| 189 |
MUSCULAR WEAKNESS |
1 |
| 190 |
MYELITIS TRANSVERSE |
1 |
| 191 |
MYELODYSPLASTIC SYNDROME |
1 |
| 192 |
MYELOSUPPRESSION |
1 |
| 193 |
MYXOEDEMA |
1 |
| 194 |
NASAL DISCOMFORT |
1 |
| 195 |
NEOPLASM |
1 |
| 196 |
NEOPLASM MALIGNANT |
1 |
| 197 |
NEUROPATHY PERIPHERAL |
1 |
| 198 |
NOCTURIA |
1 |
| 199 |
NONSPECIFIC REACTION |
1 |
| 200 |
NORMAL NEWBORN |
1 |
| 201 |
OBSTRUCTION |
1 |
| 202 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
| 203 |
OEDEMATOUS PANCREATITIS |
1 |
| 204 |
OSTEONECROSIS OF JAW |
1 |
| 205 |
PAIN |
1 |
| 206 |
PAIN IN EXTREMITY |
1 |
| 207 |
PANCREATITIS ACUTE |
1 |
| 208 |
PAPILLOEDEMA |
1 |
| 209 |
PERIPHERAL ISCHAEMIA |
1 |
| 210 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
| 211 |
PLATELET COUNT INCREASED |
1 |
| 212 |
PLEURAL EFFUSION |
1 |
| 213 |
POISONING DELIBERATE |
1 |
| 214 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
| 215 |
PRODUCT CONTAINER ISSUE |
1 |
| 216 |
PRODUCT ODOUR ABNORMAL |
1 |
| 217 |
PRODUCT PACKAGING ISSUE |
1 |
| 218 |
PRODUCT PREPARATION ERROR |
1 |
| 219 |
PRODUCT PREPARATION ISSUE |
1 |
| 220 |
PRODUCT TAMPERING |
1 |
| 221 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
| 222 |
PRODUCT USE ISSUE |
1 |
| 223 |
RASH |
1 |
| 224 |
RESPIRATORY ARREST |
1 |
| 225 |
RESPIRATORY DISTRESS |
1 |
| 226 |
RETINAL HAEMORRHAGE |
1 |
| 227 |
SEPTIC SHOCK |
1 |
| 228 |
SHOCK |
1 |
| 229 |
SLEEP DISORDER |
1 |
| 230 |
STEATORRHOEA |
1 |
| 231 |
STRONGYLOIDIASIS |
1 |
| 232 |
SUBARACHNOID HAEMORRHAGE |
1 |
| 233 |
SWEAT GLAND TUMOUR |
1 |
| 234 |
TESTICULAR ATROPHY |
1 |
| 235 |
THERAPY NON-RESPONDER |
1 |
| 236 |
THROMBOCYTOSIS |
1 |
| 237 |
THYROID DISORDER |
1 |
| 238 |
TOXIC ENCEPHALOPATHY |
1 |
| 239 |
VENOOCCLUSIVE DISEASE |
1 |
| 240 |
VENOOCCLUSIVE LIVER DISEASE |
1 |
| 241 |
VICTIM OF CHEMICAL SUBMISSION |
1 |
| 242 |
VICTIM OF HOMICIDE |
1 |
| 243 |
VITAMIN B COMPLEX DEFICIENCY |
1 |
| 244 |
WEIGHT DECREASED |
1 |
| 245 |
WERNICKE^S ENCEPHALOPATHY |
1 |
| 246 |
WHITE BLOOD CELL COUNT DECREASED |
1 |